Cotiviti (COTV) Alert: Johnson Fistel Investigates Proposed Sale of Cotiviti Holdings, Inc.; Is $44.75 a Fair Price?

SAN DIEGO, June 19, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Cotiviti Holdings, Inc. (NYSE: COTV) ("Cotiviti") breached their fiduciary duties in connection with the proposed sale of the Company to Veritas Capital. Cotiviti provides analytics-driven payment accuracy and spend management solutions primarily for the healthcare sector in the United States, Canada, the United Kingdom, and India.

On June 19, 2018, Cotiviti announced that it had signed a definitive merger agreement with Veritas Capital. Under the terms of the agreement, Cotiviti shareholders will receive $44.75 per share in cash.

The investigation concerns whether the Cotiviti board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Cotiviti shares of common stock.

Nationally recognized Johnson Fistel is investigating whether the proposed deal price represents adequate consideration, especially given Wall Street analysts' projections for Cotiviti future earnings and revenue growth.

If you are a shareholder of Cotiviti and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker ([email protected]) at 619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker
619-814-4471
[email protected]

SOURCE Johnson Fistel, LLP